#Cholangiocarcinoma Pipeline Revenue
Explore tagged Tumblr posts
Visit Tumblr Blog
Explore Tumblr blogs with no restrictions, modern design and the best experience.
Last Seen Tumblr Blogs
Fun Fact
If you dial 1-866-584-6757, you can leave an audio post for your followers.
Text
Cholangiocarcinoma Pipeline Market 2022 Insights and Forecast to 2029 Explored In Latest Research
Global Cholangiocarcinoma Pipeline Market Overview and Analysis:
The Worldwide Cholangiocarcinoma Pipeline Market research by Pharmaresearchconsulting Intellect contains all the market definitions, classifications, segments, applications, engagements, and market trends a user needs to succeed in the market. In order to define the market’s definition, categorization, procedures, and interactions for the industry’s global Cholangiocarcinoma Pipeline market, the study is also essential. Complete business profiles of the leading firms and rivals in the international Cholangiocarcinoma Pipeline industry that are influencing the market and establishing significant trends are also included in the research.
For more information about the report:
The Global Cholangiocarcinoma Pipeline market size is expected to expand at a CAGR of 12.16 % during 2022-2029.
#Cholangiocarcinoma Pipeline Industry Growth#Cholangiocarcinoma Pipeline Revenue#Cholangiocarcinoma Pipeline Market#Cholangiocarcinoma Pipeline Market 2022#Cholangiocarcinoma Pipeline Market Price#Cholangiocarcinoma Pipeline Market Size#Cholangiocarcinoma Pipeline Market Opportunity#Cholangiocarcinoma Pipeline Market Trend#Cholangiocarcinoma Pipeline Market Scope
0 notes
Text
Light Activated Therapies Market: Focus on Photodynamic Therapies, Photoimmunotherapies and Photothermal Therapies, 2021-2030
To order this 140+ page report, which features 80+ figures and 120+ tables, please visit https://www.rootsanalysis.com/reports/light-activated-therapies-market.html
Key Inclusions
§ A detailed assessment of the current market landscape of light activated therapies, with respect to current status of development (preclinical / discovery, phase I, phase I / II, phase II, phase II / III, phase III and approved), type of light activated therapy (photodynamic therapy, photoimmunotherapy and photothermal therapy), therapeutic area (oncological disorders (solid tumor), dental disorders, skin disorders, oncological disorders (hematological cancer) and others), type of photosensitive dye (methylene blue, phthalocyanine dye, indocyanine green, toluidine blue and phenothiazine hydrochloride), type of light (red light, blue light, infrared light, near-infrared light, visible light, ultraviolet light and daylight), target patient segment (children, adults and elderly patients), type of therapy (monotherapy and combination therapy), type of developer (industry / non-industry) and popular target indications (periodontitis, actinic keratosis, basal cell carcinoma, head and neck cancer, lung cancer, cholangiocarcinoma, dental caries, squamous cell carcinoma, acne, bladder cancer, COVID-19, pancreatic cancer, prostate cancer and others). In addition, the chapter includes analysis on the light activated therapy developer(s) based on various relevant parameters, including year of establishment, company size, location of headquarters and most active players (in terms of number of pipeline candidates).
§ Detailed profiles of marketed and late stage (phase III) clinical products; each profile features an overview of the company, therapy overview, clinical development status, clinical trial endpoints, dosage information, key insights, clinical trial endpoints and estimated sales revenue (2021-2030).
§ An in-depth analysis of completed, ongoing and planned clinical studies of various light activated therapies based on relevant parameters, such as trial registration year, study design and trial phase, type of masking and type of intervention model, year and trial recruitment status, type of sponsor, most active industry and non-industry players (in terms of number of registered trials conducted), purpose of study, emerging focus area, location of trial, and key geographical regions.
§ An analysis of patents filed / granted related to light activated therapies, till 2021. The instances have been analyzed based on various relevant parameters, such as publication year, type of patent, patent age, geographical location, CPC symbols, emerging focus areas, leading patent assignees, leading industry and non-industry players (in terms of number of patents filed / granted), patent benchmarking and valuation.
§ Elaborate profiles of companies (shortlisted based on phase of development of the lead drug) including brief overview of the company, its financial information (if available), product portfolio, recent developments and an informed future outlook.
The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:
§ Target Indication
§ Head and Neck Cancer
§ Actinic Keratosis
§ Macular Degeneration,
§ Polypoidal Choroidal Vasculopathy
§ Cervical Intraepithelial Neoplasia
§ Bladder Cancer
§ Barrett’s Esophagus
§ Gastric Cancer
§ Lung Cancer
§ Port-Wine Stain
§ Others
§ Key Players
§ Key Geographical Regions
§ North America
§ Europe
§ Asia Pacific
To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/light-activated-therapies-market.html
Key Questions Answered
§ What are the prevalent R&D trends related to light activated therapies?
§ What are the key therapeutic areas for which light activated therapies have been / are being developed?
§ What are the key challenges faced by stakeholders engaged in the manufacturing of light activated therapies?
§ Who are the leading industry and non-industry players engaged in the development of light activated therapies?
§ Across which geographies, extensive research related to light activated therapies is being conducted?
§ Which factors are likely to influence the evolution of this upcoming market?
§ How is the current and future market opportunity likely to be distributed across key market segments?
You may also be interested in the following titles:
1. Fc Fusion Therapeutics Market: Industry Trends and Global Forecasts, 2020-2030
2. CRISPR Based Therapeutics Market: Industry Trends and Global Forecasts, 2020-2030
3. Cell and Gene Therapy CROs Market (2nd Edition): Industry Trends and Global Forecasts, 2021-2030
4. TIL-based Therapies Market: Industry Trends and Global Forecasts, 2021-2030
5. TCR-based Therapies Market: Industry Trends and Global Forecasts, 2021-2030
6. CAR-T Cell Therapies Market: Industry Trends and Global Forecasts, 2021-2030
Contact Details
Ben Johnson
+1 (415) 800 3415
Roots Analysis
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis.com
Medium: https://medium.com/@RootsAnalysis
Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/
Quora: https://rootsanalysisinsights.quora.com/
0 notes
Text
Cervical Cancer Market
Cervical Cancer occurs in the cells of the cervix and usually originates in the transformation zone of the cervix, and spreads to regional lymph nodes with parametrial invasion also common.
Most cases of cervical cancer are caused by infection with human papillomavirus (HPV). Apart from HPV, other factors that can also increase the risk include: human immunodeficiency virus (HIV), chlamydia, smoking, obesity, family history of cervical cancer, diet low in fruits and vegetables, taking birth control pills, and having three full-term pregnancies.
DelveInsight's "Cervical Cancer Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Cervical Cancer, historical and forecasted epidemiology as well as the Cervical Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some facts of the Cervical Cancer Market Report:
The incidence of cervical cancer in 7MM (US, UK, Germany, Italy, Spain, France & Japan) in 2020 is expected to be 43,712.
In the 7MM, the USA is the major contributor to the cervical cancer market revenue in 2020, and the region is expected to hold its position in the upcoming years.
Key companies propelling the market size include Regeneron, AstraZeneca, Lovance, Zeria Pharmaceutical, Seattle Genetics/Genmab, Agenus Bio, Roche, Akeso Biopharma and Vaccibody/Roche, among others.
Launch of cervical cancer pipeline therapies, including Cemiplimab (Regeneron), Durvalumab (AstraZeneca), LN-145 (Iovance), Z-100 (Zeria Pharmaceutical), Tisotumab vedotin (Seattle Genetics/Genmab) in the next decade is expected to propel the market growth.
Request for Free Sample Report: https://www.delveinsight.com/sample-request/cervical-cancer-market
“As per WHO estimates, Cervical Cancer is the fourth most common cancer in women.”
Clinical presentation depends mainly on the location and extent of disease. Precancerous changes or very early stage disease are usually asymptomatic and are detected on a cervical smear. Symptoms usually appear when the tumour causes spontaneous or contact bleeding, or pain if lymph nodes are involved.
Typical cervical cancer symptoms are: unusual bleeding, such as in between periods, after sex, or after menopause, vaginal discharge that looks or smells different than usual, pain in the pelvis, needing to urinate more often, pain during urination etc.
All women are at risk for cervical cancer. It occurs most often in women over age 30. There’s more than one kind of cervical cancer.
Squamous cell carcinoma-This forms in the lining of cervix. It’s found in up to 90% of cases.
Adenocarcinoma-This forms in the cells that produce mucus.
Mixed carcinoma-This has features of the two other types.
DelveInsight estimated that cervical cancer is most often diagnosed in women between the ages of 35 and 44, with the average age at diagnosis being 50. The late diagnosis in women is a consequence of a lack of vaccination and screening in women in the early stages of their lives.
Request for Free Sample Report: https://www.delveinsight.com/sample-request/cervical-cancer-market
Some of the Cervical Cancer Companies are:
Regeneron Pharmaceuticals
Zeria Pharmaceutical
Advaxis
AstraZeneca
Immunitor
And Many Others
Cervical cancer Drug Covered:
Libtayo
Z-100
ADXS11–001
IMFINZ
V3-Cervix
And Many Others
Table of Contents:
1. Key Insights
2. Executive Summary of Cervical Cancer
3. Competitive Intelligence Analysis for Cervical Cancer
4. Cervical Cancer: Market Overview at a Glance
5. Cervical Cancer: Disease Background and Overview
6. Patient Journey
7. Cervical Cancer Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Cervical Cancer Treatment
11. Marketed Products
12. Emerging Therapies
13. Cervical Cancer: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Cervical Cancer
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
Request for Detailed TOC: https://www.delveinsight.com/sample-request/cervical-cancer-market
Other Reports:
Intrahepatic Cholangiocarcinoma Market
Barett Esophagus Market
Aortic Stenosis Market
Chemotherapy Induced Diarrhea Market
Immunologic Deficiency Syndrome Market
Binge Eating Disorder Market
#Cervical Cancer market report#Cervical Cancer symptoms#Cervical Cancer Launch Insight#Cervical Cancer Epidemiology#Cervical Cancer treatment#Cervical Cancer market forecast#Cervical Cancer market trends
0 notes
Text
Global Market Study on Bile Duct Cancer Treatment,Industry Analysis , Trends & Forcaste 2017- 2027
The report ‘Bile Duct Cancer (Cholangiocarcinoma) Treatment Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)’ is a comprehensive compilation on the bile duct cancer treatment market and contains exclusive information regarding the market analysis, growth and forecasts for the period 2017 to 2025. Bile ducts are a series of thin tubes that reach from the liver to the small intestine. The major function of bile ducts is to move a fluid called bile from the liver and gallbladder to the small intestine, where it helps digest the fats in food. Bile duct cancer starts when the healthy cells in the bile duct begin to grow out of control to form tumors. Cancer can develop in any part of the bile duct system and can be classified into three types based on the location -Intrahepatic bile duct cancers: These cancers develop in the smaller bile duct branches inside the liver from the left and right hepatic branches. About 5% to 10% of bile duct cancers are intrahepatic.
Request For Sample Report : http://www.mrrse.com/sample/3262
Extrahepatic cholangiocarcinoma: These cancers develop in the part of the bile duct that is outside the liver. These are of two types:
Perihilar (also called hilar) bile duct cancers: These cancers develop at the hilum, where the left and right hepatic ducts have joined and are just leaving the liver. These are also called Klatskin tumors.
Distal bile duct cancers: These cancers are found further down the bile duct, closer to the small intestine.
Bile duct cancer is a type of biliary tract cancer, which also includes gall bladder cancer; however gall bladder cancer is not included in the scope of this report, which largely focuses on intrahepatic bile duct tumors, perihilar bile duct tumors, and distal bile duct tumors.
Report Inclusions
This report is divided into four distinct parts. The first section consists of the introduction to the bile duct cancer treatment market. The second section of the report consists of the regional bile duct cancer treatment market analysis and forecast. The third section contains the competitive landscape of the global bile duct cancer treatment market and gives a list of the important players operating in this niche market. The last section of the report consists of the global bile duct cancer treatment market analysis 2012-2016 and forecast 2017-2025 by region, by treatment type, by disease indication and by distribution channel.
In the introduction, the pertinent market numbers of the global bile duct cancer treatment market are given along with the CAGR for the forecast period 2017-2025. The introduction also contains an executive summary of this detailed report through which the report audiences can have a cursory glance at this vast market. The report also contains detailed definitions of bile duct cancer and its different types along with the definitions of the various kinds of treatments administered in cases of bile duct cancer. In addition, the introduction also lists the macroeconomic factors influencing the global bile duct cancer treatment market. An opportunity analysis of the global bile duct cancer treatment market is also presented in the introduction. Along with this, the regulatory scenarios of various regions in the global bile duct cancer treatment market are also listed. Also, a list of products that are in the pipeline for the treatment of bile duct cancer is also given in the introduction.
Browse Full Report With TOC : http://www.mrrse.com/bile-duct-cancer-treatment-market
The second section of the report contains the regional bile duct cancer treatment market analysis and forecast. In this section, the regional drivers, restraints and trends are given so that the report audience knows what factors are aiding the growth of this market and what factors are hampering the growth of this market across the various assessed regions. Besides the drivers and restraints, the trends that are applicable in the global bile duct cancer treatment market are also discussed region-wise in this section of the report.
An important section of the report focuses on the competitive landscape of the global bile duct cancer treatment market. This part constitutes information on the key market players. This competition landscape gives a dashboard view of the key companies operating in the global bile duct cancer treatment market along with their important information and broad strategy adopted to stay as leaders in the global bile duct cancer treatment market. Each of the leading companies is also profiled individually and important information about the company such as company details, company description, product portfolio along with key developments concerning the company and strategic analysis is presented.
The last section of the report contains the global bile duct cancer treatment market analysis and forecast as well as important market metrics such as the BPS analysis, year-on-year growth rates, absolute dollar opportunity and market attractiveness analysis of the bile duct cancer treatment market.
Why should you invest in this report?
If you are ready to enter the global bile duct cancer treatment market, then this report is a comprehensive guide and will give you crystal clear insights into this vast and lucrative market. All the aspects of bile duct cancer treatment are covered in this report and information is also given on the important regions of the world where this market is likely to boom in the near future and during the forecast period of 2017-2025 so that you can plan your strategies accordingly. Besides, through this report, you can gain a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, then this report will help you gauge the strategies that your competitors have adopted to stay as leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
A tested and proven research methodology for accurate estimation of market performance
Our research methodology leverages both primary and secondary research to collect the relevant market data. We have analyzed the global bile duct cancer treatment market by considering the revenue through extensive primary research to understand the usage patterns, historic trends, problems faced by oncologists, the required treatment developments, and most preferred drugs. Key opinion leaders have been considered for primary research including experienced healthcare professionals in various healthcare facilities at a country level. These estimates have further been validated with drug manufacturers, distributors, and suppliers.
Extensive secondary research has been carried out to understand the epidemiology of bile duct cancer, treatment rate, adoption rate, regulatory scenarios, average selling price, reimbursement scenario, etc., by referring to published scientific literature from various databases such as the WHO, PubMed, Springer, and Wiley among many others. We have also analyzed various companies’ annual reports, investor presentations, SEC filings, 10k reports, and press releases to fetch substantial information about the market size, trends, opportunities, drivers, and restraints.
Market Segmentation
Treatment Type
By Treatment Type
By Services Spending
Gemcitabine Combination Therapy
5-fluorouracil Combination Therapy
Capecitabine Combination Therapy
Gemcitabine Single Agent
Radiation Therapy
Surgery
Brachytherapy Services
External Beam Radiation Therapy (EBRT)
Disease Indication
Intrahepatic Bile Duct Cancer
Extrahepatic Bile Duct Cancer
Perihilar Bile Duct Cancer
Distal Extrahepatic Bile Duct Cancer
Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Region
North America
Latin America
Europe
Asia Pacific (APAC)
Middle East Africa (MEA)
Enquiry About This Report : http://www.mrrse.com/enquiry/3262
About Us
Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.
MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.
Contact
State Tower 90, State Street Suite 700 Albany, NY - 12207 United States
Telephone: +1-518-730-0559 Email: [email protected]
Google+: https://plus.google.com/u/0/109558601025749677847/posts
Linked in: https://www.linkedin.com/company/mrrse
Twitter: https://twitter.com/MRRSEmrrse
0 notes
Text
Light Activated Therapies Market: Focus on Photodynamic Therapies, Photoimmunotherapies and Photothermal Therapies, 2021-2030
To order this 140+ page report, which features 80+ figures and 120+ tables, please visit https://www.rootsanalysis.com/reports/light-activated-therapies-market.html
Key Inclusions
§ A detailed assessment of the current market landscape of light activated therapies, with respect to current status of development (preclinical / discovery, phase I, phase I / II, phase II, phase II / III, phase III and approved), type of light activated therapy (photodynamic therapy, photoimmunotherapy and photothermal therapy), therapeutic area (oncological disorders (solid tumor), dental disorders, skin disorders, oncological disorders (hematological cancer) and others), type of photosensitive dye (methylene blue, phthalocyanine dye, indocyanine green, toluidine blue and phenothiazine hydrochloride), type of light (red light, blue light, infrared light, near-infrared light, visible light, ultraviolet light and daylight), target patient segment (children, adults and elderly patients), type of therapy (monotherapy and combination therapy), type of developer (industry / non-industry) and popular target indications (periodontitis, actinic keratosis, basal cell carcinoma, head and neck cancer, lung cancer, cholangiocarcinoma, dental caries, squamous cell carcinoma, acne, bladder cancer, COVID-19, pancreatic cancer, prostate cancer and others). In addition, the chapter includes analysis on the light activated therapy developer(s) based on various relevant parameters, including year of establishment, company size, location of headquarters and most active players (in terms of number of pipeline candidates).
§ Detailed profiles of marketed and late stage (phase III) clinical products; each profile features an overview of the company, therapy overview, clinical development status, clinical trial endpoints, dosage information, key insights, clinical trial endpoints and estimated sales revenue (2021-2030).
§ An in-depth analysis of completed, ongoing and planned clinical studies of various light activated therapies based on relevant parameters, such as trial registration year, study design and trial phase, type of masking and type of intervention model, year and trial recruitment status, type of sponsor, most active industry and non-industry players (in terms of number of registered trials conducted), purpose of study, emerging focus area, location of trial, and key geographical regions.
§ An analysis of patents filed / granted related to light activated therapies, till 2021. The instances have been analyzed based on various relevant parameters, such as publication year, type of patent, patent age, geographical location, CPC symbols, emerging focus areas, leading patent assignees, leading industry and non-industry players (in terms of number of patents filed / granted), patent benchmarking and valuation.
§ Elaborate profiles of companies (shortlisted based on phase of development of the lead drug) including brief overview of the company, its financial information (if available), product portfolio, recent developments and an informed future outlook.
The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:
§ Target Indication
§ Head and Neck Cancer
§ Actinic Keratosis
§ Macular Degeneration,
§ Polypoidal Choroidal Vasculopathy
§ Cervical Intraepithelial Neoplasia
§ Bladder Cancer
§ Barrett’s Esophagus
§ Gastric Cancer
§ Lung Cancer
§ Port-Wine Stain
§ Others
§ Key Players
§ Key Geographical Regions
§ North America
§ Europe
§ Asia Pacific
To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/light-activated-therapies-market.html
Key Questions Answered
§ What are the prevalent R&D trends related to light activated therapies?
§ What are the key therapeutic areas for which light activated therapies have been / are being developed?
§ What are the key challenges faced by stakeholders engaged in the manufacturing of light activated therapies?
§ Who are the leading industry and non-industry players engaged in the development of light activated therapies?
§ Across which geographies, extensive research related to light activated therapies is being conducted?
§ Which factors are likely to influence the evolution of this upcoming market?
§ How is the current and future market opportunity likely to be distributed across key market segments?
You may also be interested in the following titles:
1. Fc Fusion Therapeutics Market: Industry Trends and Global Forecasts, 2020-2030
2. CRISPR Based Therapeutics Market: Industry Trends and Global Forecasts, 2020-2030
3. Cell and Gene Therapy CROs Market (2nd Edition): Industry Trends and Global Forecasts, 2021-2030
4. TIL-based Therapies Market: Industry Trends and Global Forecasts, 2021-2030
5. TCR-based Therapies Market: Industry Trends and Global Forecasts, 2021-2030
6. CAR-T Cell Therapies Market: Industry Trends and Global Forecasts, 2021-2030
Contact Details
Ben Johnson
+1 (415) 800 3415
Roots Analysis
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis.com
Medium: https://medium.com/@RootsAnalysis
Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/
Quora: https://rootsanalysisinsights.quora.com/
0 notes